INTRAPULMONARY PERCUSSIVE VENTILATION (IPV®)

GENERAL CLINICAL DESCRIPTION OF INTRAPULMONARY PERCUSSIVE VENTILATION (IPV®)

Who can potentially benefit from IPV® Therapy?

IPV® therapy is a combination of Therapeutic Aerosol, Volume Oriented IPPB, CPAP and Chest Physiotherapy, directed toward the mobilization and raising of retained endobronchial secretions and the resolution of diffuse patchy atelectasis. Therefore, Patients who typically would be expected to respond to these therapeutic regimes, would encompass: Institutionalized Patients with compromised cardiopulmonary functions secondary to accidental trauma, burns, surgical protocols, myopathic limitations and acute insults to chronic obstructive pulmonary diseases.

Such potentials would include, Acute patients requiring Emergency Room stabilization because of cardiopulmonary shock, acute obstructive pulmonary disease, neuromuscular disorders, smoke inhalation, aspiration of intrapulmonary irritants, left congestive heart failure complicated with acute pulmonary edema. Chronic Patients with obstructive pulmonary disease, presenting with mild to moderate or severe clinical symptoms. Patients with combination Fibrotic Obstructive Disease with Cor Pulmonale etc.